Pfizer’s CEO Albert Bourla disclosed that the company recently met with the Trump administration to discuss lowering U.S.

The vaginitis treatment drug market size stands at USD 3.32 billion in 2024. The industry size is anticipated to be worth USD 5.32 billion by 2034. Revenues are projected to rise at a 4.8% CAGR until ...

By Bhanvi Satija and Christy Santhosh (Reuters) -Talks with the Trump administration about lowering U.S. drug prices have so ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...

This update covers current health news, focusing on Parvus Asset Management's influence on Novo Nordisk's CEO selection, ...

The World Health Organization estimates a surge in new cancer cases to 23.6 million per year by 2030. This alarming projection underscores the urgent need for effective cancer treatments, positioning ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

The decree signed by Donald Trump to drastically reduce drug prices in the United States could, indirectly, benefit ...

BMY is looking to expand its pipeline/portfolio as the legacy portfolio is being adversely impacted due to continued generic ...

DataM Intelligence | competitive Intelligence Gene therapies, exon-skipping drugs and next-gen steroids are reshaping Duchenne muscular dys ...